ELVN — Enliven Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Enliven Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-Q	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.9	88.2	90.3	75.5	253
Prepaid Expenses
Total Other Current Assets
Total Current Assets	30.6	90.4	92.7	77.8	266
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.442	0.349	0.775	1.52	1.06
Other Long Term Assets
Total Assets	33.3	90.8	93.6	83.3	272
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.2	6.25	7.21	9.71	25.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.38	6.41	7.62	10.4	26
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	28.9	84.4	86	72.9	246
Total Liabilities & Shareholders' Equity	33.3	90.8	93.6	83.3	272
Total Common Shares Outstanding